This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why

As reported in an SEC filing on Friday, New York City-based Armistice Capital sold 1,458,192 shares of PTC Therapeutics (NASDAQ:PTCT) during the third quarter, reducing its position by $30.2 million in value.According to a filing with the U.S. Securities and Exchange Commission released on Friday, Armistice Capital reduced its stake in PTC Therapeutics (NASDAQ:PTCT) by nearly 1.5 million shares in the third quarter. The position now stands at 3.3 million shares worth $201.1 million as of the quarter’s end.The trade was a reduction; the holding now represents 2.5% of Armistice’s 13F reportable assetsContinue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool